Search

everythinglearnresearchcommunity

for

Search:↓

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

DHEA affects multiple receptors and may help with metabolic issues, but its safety and effectiveness in humans are unclear.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

There is no gold standard treatment for hidradenitis suppurativa due to insufficient evidence.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

Test thyroid function in all obese patients and prioritize weight loss for hormonal balance.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.

Transgender patients in critical care need better-trained medical staff and specific guidelines.

Bariatric surgery improves ovulation rates in women with PCOS and obesity better than medical therapy.

"HairSentinel" accurately detects hairfall trends using simple user data, helping identify health risks early.

Collaboration and innovation are key to developing effective, safe hair loss treatments.

PCOS skin symptoms need personalized treatment and psychological support to improve quality of life.

Women with PCOS often experience depression and anxiety, affecting their quality of life.

A new tool can analyze hair to detect changes due to hormones, genetics, and aging.

PCOS involves hormonal imbalance, cysts, and ovulation issues, affecting health and increasing disease risks.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Menopause can cause hair thinning and texture changes due to hormonal and metabolic shifts.

Transgender youth have more sleep disorders, but gender-affirming therapy may help reduce them.

Men generally face more severe COVID-19 outcomes than women, partly due to hormonal differences.

Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.

Metformin improves quality of life, emotional health, and sex life in women with polycystic ovary syndrome.

Women with hair loss often have deficiencies in iron, vitamins, minerals, and lower thyroid function, suggesting the need for nutritional and hormonal treatment.

PCOS is common among Indian women, often with metabolic issues, needing better management strategies.

People with hypothyroidism and hair loss often have more hair and scalp issues than those without thyroid problems.

A mild botulinum toxin injection improved sperm production and movement in aging mice.

Resveratrol shows health benefits but faces challenges in effectiveness and regulation.

Scalp conditions change with age, affecting hair health.